Triglyceride-Glucose Index is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients with HBV-Related Liver Cirrhosis
Su-Hua Yang,Yi-Shan He,Shu-Qin Zheng,Xiu-Jun Zhang,Hong Dai,Yuan Xue
DOI: https://doi.org/10.2147/jhc.s454037
2024-04-18
Journal of Hepatocellular Carcinoma
Abstract:Su-Hua Yang, 1, &ast Yi-Shan He, 2, &ast Shu-Qin Zheng, 3 Xiu-Jun Zhang, 3 Hong Dai, 1, &ast Yuan Xue 2, 3, &ast 1 Department of General Surgery, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu Province, People's Republic of China; 2 Department of Infectious Diseases, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu Province, People's Republic of China; 3 Institute of Hepatology, Changzhou Third People's Hospital, Changzhou, Jiangsu Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Hong Dai, Department of General Surgery, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu Province, People's Republic of China, Email Yuan Xue, Institute of Hepatology, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, No. 300 Lanling North Road, Changzhou, Jiangsu, 213000, People's Republic of China, Tel +86 519 82009059, Email Aim: This study aimed to explore the effects of the triglyceride-glucose (TyG) index on hepatocellular carcinoma (HCC) development in patients with hepatitis B virus (HBV)-related liver cirrhosis (LC). Methods: A total of 242 patients with HBV-related LC were enrolled and followed-up. Logistic regression analysis was performed to investigate risk factors for HCC. Results: The median follow-up time was 37 months (range: 6– 123 months). At the end of the follow-up, 11 (11.3%) patients with compensated cirrhosis (CC) and 45 (31.0%) with decompensated cirrhosis (DC) developed HCC. The TyG index was higher in the HCC group than in the non-HCC group (P=0.05). Univariate analysis showed that age (P< 0.01), DC (P< 0.01), TyG index (P=0.08), albumin (ALB) level (P=0.05), platelet (PLT) count (P< 0.01), and HBV DNA positivity (P< 0.01) were associated with HCC development. Multivariate analysis revealed that age, DC, TyG index, PLT count, and HBV DNA positivity were independent risk factors for HCC development (P=0.01, 0.01, < 0.01, 0.05, and < 0.01, respectively). For patients with DC, multivariate logistic regression analysis revealed that age, TyG index, and HBV DNA positivity were independent risk factors for HCC development (all P< 0.05). A new model encompassing age, DC, TyG, PLT, and positive HBV DNA had optimal predictive accuracy in patients with DC or CC, with a cutoff value of 0.197. The areas under the receiver operating characteristic curves (AUROCs) of the model for predicting HCC development in patients with LC, DC, and CC were 0.778, 0.721, and 0.783, respectively. Conclusion: TyG index was identified as an independent risk factor for HCC development in patients with LC. Keywords: hepatocellular carcinoma, triglyceride-glucose index, insulin resistance, liver cirrhosis, decompensated cirrhosis In China, liver cancer is one of the most common malignant tumors and the second leading cause of cancer-related deaths. 1 Hepatocellular carcinoma (HCC), which accounts for 75–85% of primary liver cancers, is a public health burden. 2 Hepatitis B virus (HBV)- or hepatitis C virus (HCV)-related liver cirrhosis (LC) is a major risk factor for HCC in the Asia-Pacific region. 1 LC is a pathological stage characterized by diffuse fibrosis, pseudolobule formation, and the proliferation of blood vessels inside and outside the liver. In contrast to compensated cirrhosis (CC), decompensated cirrhosis (DC) is characterized by obvious portal hypertension and complications such as ascites, gastrointestinal bleeding, hepatic encephalopathy, and hepatorenal syndrome. Owing to serious liver damage, patients with DC have a high Child-Pugh score and are ineligible to undergo partial hepatectomy. Approximately 31.8% of patients with HBV-related DC develop HCC during the 5-year follow-up. 3 Patients with CC and DC have different physical status. In a previous study, we showed that the prediction accuracy of noninvasive models was not potent in patients with DC. 4 Considering that the HCC incidence is high and the prognosis is poor in patients with DC, additional accuracy prediction models are essential. Insulin resistance (IR) is a condition in which insulin is less effective in promoting glucose uptake and utilization. This results in the secretion of excessive insulin by the body, which causes hyperinsulinemia to maintain stable blood sugar levels. These conditions play crucial roles in chronic metabolic diseases. 5 The euglyce -Abstract Truncated-
oncology